Predictive signatures of 19 antibiotics-induced Escherichia coli proteomes

ABSTRACT: Identifying the mode of action (MOA) of antibacterial compounds is the fundamental basis for the development of new antibiotics, and the challenge increases with the emerging secondary and indirect effect from antibiotic stress. Although various omics-based system biology approaches of defining antibiotic MOA are currently available, they still need improved throughput, accuracy and comprehensiveness. Using high resolution accurate mass (HR/AM) based proteomics, we present here a comprehensive reference map of proteomic signatures of Escherichia coli under antibiotics challenge. With state-of-the-art label-free approach, we quantified > 1,500 protein groups in response to 19 FDA-approved antibiotics. Applying several machine learning techniques, we derived a panel of 14 proteins that can be used to classify antibiotics into different MOAs with nearly 100% accuracy. Interestingly, these proteins tend to mediate diverse bacterial cellular and metabolic processes. Transcriptomic level profiling correlates well with changes in protein expression in discriminating different antibiotics. Such expression signatures will aid future studies in identifying MOA of unknown compounds and facilitate the discovery of novel antibiotics. In summary, our study offers a practical approach for effective and rapid proteomic profiling, establishes a high quality reference compendium of microbial proteome in response to a wide range of antibiotics exposure, and provides a previously undescribed group of proteins and RNAs that allows rapid antibiotic classification and MOA determination.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Escherichia Coli

SUBMITTER: Yanbao Yu  

LAB HEAD: Yanbao Yu

PROVIDER: PXD016074 | Pride | 2020-07-23

REPOSITORIES: Pride